logo

24.98

24.98 (-0.61%)

As of Jun 14, 2022

Prometheus Biosciences, Inc. [RXDX]

Source: 

Company Overview

Prometheus Biosciences, Inc is a clinical-stage biotechnology company pioneering a precision medicine approach to the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment of immune-mediated diseases, starting first with inflammatory bowel disease (IBD).

CountryUnited States
Headquarterssan diegocalifornia
Phone Number(858) 422-4300
Industry
manufacturing
CEOMark C. Mckenna
Websiteprometheusbiosciences.com